564 related articles for article (PubMed ID: 15212355)
1. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial.
Sanz M; Tonetti MS; Zabalegui I; Sicilia A; Blanco J; Rebelo H; Rasperini G; Merli M; Cortellini P; Suvan JE
J Periodontol; 2004 May; 75(5):726-33. PubMed ID: 15212355
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
[TBL] [Abstract][Full Text] [Related]
3. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
Sculean A; Donos N; Blaes A; Lauermann M; Reich E; Brecx M
J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541
[TBL] [Abstract][Full Text] [Related]
4. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial.
Zucchelli G; Bernardi F; Montebugnoli L; De SM
J Periodontol; 2002 Jan; 73(1):3-12. PubMed ID: 11846197
[TBL] [Abstract][Full Text] [Related]
5. Enamel matrix proteins in the regenerative therapy of deep intrabony defects.
Tonetti MS; Lang NP; Cortellini P; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Mayfield L; Rossi R; Silvestri M; Tiedemann C; Topoll H; Vangsted T; Wallkamm B
J Clin Periodontol; 2002 Apr; 29(4):317-25. PubMed ID: 11966929
[TBL] [Abstract][Full Text] [Related]
6. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
[TBL] [Abstract][Full Text] [Related]
7. Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: an 8-year follow-up split-mouth study.
Sculean A; Schwarz F; Miliauskaite A; Kiss A; Arweiler N; Becker J; Brecx M
J Periodontol; 2006 Nov; 77(11):1879-86. PubMed ID: 17076614
[TBL] [Abstract][Full Text] [Related]
8. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
Mengel R; Schreiber D; Flores-de-Jacoby L
J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
[TBL] [Abstract][Full Text] [Related]
9. Treatment of intrabony defects with enamel matrix proteins or bioabsorbable membranes. A 4-year follow-up split-mouth study.
Sculean A; Donos N; Miliauskaite A; Arweiler N; Brecx M
J Periodontol; 2001 Dec; 72(12):1695-701. PubMed ID: 11811505
[TBL] [Abstract][Full Text] [Related]
10. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
[TBL] [Abstract][Full Text] [Related]
11. Generalizability of the added benefits of guided tissue regeneration in the treatment of deep intrabony defects. Evaluation in a multi-center randomized controlled clinical trial.
Tonetti MS; Cortellini P; Suvan JE; Adriaens P; Baldi C; Dubravec D; Fonzar A; Fourmousis I; Magnani C; Muller-Campanile V; Patroni S; Sanz M; Vangsted T; Zabalegui I; Pini Prato G; Lang NP
J Periodontol; 1998 Nov; 69(11):1183-92. PubMed ID: 9848527
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal class II furcation involvement in mandibular molars. Part II: secondary outcomes.
Meyle J; Gonzales JR; Bödeker RH; Hoffmann T; Richter S; Heinz B; Arjomand M; Reich E; Sculean A; Jepsen K; Jepsen S
J Periodontol; 2004 Sep; 75(9):1188-95. PubMed ID: 15515332
[TBL] [Abstract][Full Text] [Related]
13. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
[TBL] [Abstract][Full Text] [Related]
14. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration.
Sculean A; Kiss A; Miliauskaite A; Schwarz F; Arweiler NB; Hannig M
J Clin Periodontol; 2008 Sep; 35(9):817-24. PubMed ID: 18647201
[TBL] [Abstract][Full Text] [Related]
15. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
16. Clinical performance of a regenerative strategy for intrabony defects: scientific evidence and clinical experience.
Cortellini P; Tonetti MS
J Periodontol; 2005 Mar; 76(3):341-50. PubMed ID: 15857066
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 gene polymorphisms and long-term stability following guided tissue regeneration therapy.
De Sanctis M; Zucchelli G
J Periodontol; 2000 Apr; 71(4):606-13. PubMed ID: 10807125
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomized controlled clinical trial.
Tonetti MS; Cortellini P; Lang NP; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Rasperini G; Rossi R; Silvestri M; Topoll H; Wallkamm B; Zybutz M
J Clin Periodontol; 2004 Sep; 31(9):770-6. PubMed ID: 15312100
[TBL] [Abstract][Full Text] [Related]
19. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
[TBL] [Abstract][Full Text] [Related]
20. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study.
Mengel R; Soffner M; Flores-de-Jacoby L
J Periodontol; 2003 Jun; 74(6):899-908. PubMed ID: 12887004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
